These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2722132)

  • 1. Serum levels of type III procollagen peptide in diabetes mellitus.
    Triolo G; Giardina E; Zarcone MR; Seddio G; Bompiani GD
    Horm Metab Res; 1989 Feb; 21(2):77-80. PubMed ID: 2722132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
    Singhania N; Puri D; Madhu SV; Sharma SB
    QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduced resistin levels in patients with type 2 diabetes mellitus].
    Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus.
    Acerini CL; Clayton KL; Hintz R; Baker B; Watts A; Holly JM; Dunger DB
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):13-9. PubMed ID: 8796133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin concentration in non-obese and obese children with type 1 diabetes mellitus.
    Verrotti A; Basciani F; De Simone M; Morgese G; Chiarelli F
    Biomed Pharmacother; 2000 Mar; 54(2):69-73. PubMed ID: 10759289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
    Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
    Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect evidence of impairment of platelet desaturase enzymes in diabetes mellitus.
    Jones DB; Carter RD; Mann JI
    Horm Metab Res; 1986 May; 18(5):341-4. PubMed ID: 3013745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin on serum amino-terminal propeptide of type III procollagen in non-insulin-dependent diabetes mellitus.
    Sotaniemi EA; Stenbäck FG; Risteli L; Vuori JA; Rautio A; Huupponen R; Risteli J
    Diabetes Res Clin Pract; 1992 Sep; 17(3):209-15. PubMed ID: 1425160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and circulating collagen and laminin metabolites in insulin-dependent diabetic children with joint and skin manifestations.
    Veijola R; Knip M; Risteli L; Risteli J; Käär ML; Puukka R; Ilonen J
    Pediatr Res; 1993 May; 33(5):501-5. PubMed ID: 8511024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active rosette forming T-lymphocytes in diabetes mellitus.
    Uriarte A; Ventura R; Gabrera E; Perich P
    Exp Clin Endocrinol; 1987 Aug; 89(3):307-11. PubMed ID: 3499332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of type III procollagen peptide and peripheral vascular disease in diabetic patients.
    Migdalis IN; Kalogeropoulou K; Zachariadis D; Koutoulidis K; Samartzis M
    Diabetes Res Clin Pract; 1994 Apr; 23(3):179-82. PubMed ID: 7924878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood glycogen and metabolic control in diabetes mellitus.
    Segers O; Somers G; Sener A; Malaisse WJ
    Diabet Med; 1990; 7(3):207-10. PubMed ID: 2139390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.